Adempas (Riociguat) for Pulmonary Hypertension

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer

Adempas (Riociguat) by Bayer Schering

Take the Next Step With Adempas. Adempas is the first and only medicine approved by the Food and Drug Administration (FDA) for treating two types of pulmonary hypertension in adults: Chronic thromboembolic pulmonary hypertension (CTEPH) and Pulmonary arterial hypertension (PAH). Bayer HealthCare Pharmaceuticals.

Riociguat Drug Information. Prescribing information, side effects, and contraindications.

PAH Drug, Riociguat, Found Not to Alter the Effectiveness of Oral Contraceptives. Women with PAH are advised to avoid having children due to the high mortality rate associated with pregnancy in this condition. Since oral contraceptives are the most common drugs used to prevent pregnancy, it is important to understand how they interact with a drug used to treat PAH. Pulmonary Hypertension News, 05/24/2016.

Go to Stem Cell Transplants

Many thanks to our recent donors, Jack and Elizabeth Lewis. See ISN News for more donors. Click Here to Donate.


TOLL FREE HOTLINE, U.S. and Canada: 1-800-564-7099
Ask for our Free Info Packet by email or postal mail!

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses.

We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, report bad links, or update page content. Disclaimer. Privacy Policy.

The most important thing in the world to know about scleroderma is!